(opens in a new window)Microbiome analysis as a platform R&D tool for parasitic nematode disease management. Hogan et al. ISME Journal, 2019 25 June
(opens in a new window)DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen. Cole et al. Acta Biomater, 2019 9 July
(opens in a new window)ODX: A Fitness Tracker-Based Device for Continuous Bacterial Growth Monitoring. Yallapragada et al. Anal. Chem, 2019 3 September
(opens in a new window)Function2Form Bridge-Toward synthetic protein holistic performance prediction. Yallapragada et al. Proteins, 2019 7 October
(opens in a new window)Delivery of RALA/siFKBPL nanoparticles via electrospun bilayer nanofibres: An innovative angiogenic therapy for wound repair. Mulholland et al. J. Control Release, 2019 30 October
(opens in a new window)Time and region-dependent manner of increased brain derived neurotrophic factor and TrkB in rat brain after binge-like methamphetamine exposure. da Silva Santos et al. Neurosci. Lett, 2019 3 November
(opens in a new window)Effect of kinase inhibiting rnase attenuator (Kira) compounds on the formation of face-to-face dimers of inositol-requiring enzyme 1: Insights from computational modeling. Carlesso et al. Int. J. Mol. Sci, 2019 6 November
(opens in a new window)Application of a New Multiplexed Array for Rapid, Sensitive, Simultaneous and Quantitative Assessment of Spliced and Unspliced XBP1. Creedican et al. Biol. Proced. Online, 2019 15 November
(opens in a new window)FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer. Annett et al. Br. J. Cancer, 2019 27 November
(opens in a new window)Evaluating liquid biopsies for methylomic profiling of prostate cancer. Silva et al. Epigenetics, 2020 31 January
(opens in a new window)Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells. Bajor et al. Antioxidants. 2020 16 April
(opens in a new window)Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer Patients. Mazo et al. Cancers (Basel), 2020 1 May
(opens in a new window)Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects. Tabrizi et al. Mol. Pharm, 2020 6 July
(opens in a new window)Periodic propagating waves coordinate RhoGTPase network dynamics at the leading and trailing edges during cell migration. Bolado-Carrancio et al. Elife, 2020 24 July
(opens in a new window)Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland. Kearns et al. Cancers. 2020 16 July
(opens in a new window)Characterization of FFPE-induced bacterial DNA damage and development of a repair method. Flores Bueso et al. Biology Methods and Protocols, 2020 27 July
(opens in a new window)The Molecular Effects of a High Fat Diet on Endometrial Tumour Biology. Wilkinson et al. Life. 2020 10 September
(opens in a new window)A functional genomic screen identifies the deubiquitinase USP11 as a novel transcriptional regulator of ERα in breast cancer. Dwane et al. Cancer Res, 2020 1 October
(opens in a new window)High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells. Slater et al. Cancers (Basel), 2020 13 Oct
(opens in a new window)Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models. O’Farrell et al. Cancers (Basel), 2020 Oct 14
(opens in a new window)A novel cell permeability assay for macromolecules. Flores Bueso et al. BMC Mol. Cell Biol, 2020 30 October
(opens in a new window)ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis. Charmsaz et al. BMC Medicine, 2020 19 November
(opens in a new window)Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer. Watson et al. Cancers (Basel), 2020 27 November
(opens in a new window)A Chemo-Genomic Approach Identifies Diverse Epigenetic Therapeutic Vulnerabilities in MYCN-Amplified Neuroblastoma. Krstic et al. Front. Cell Dev. Biol, 2021 21 April
(opens in a new window)A systematic analysis of signaling reactivation and drug resistance. Kholodenko et al. Cell Rep, 2021 21 April
(opens in a new window)Pepblock Builder VR – An Open-Source Tool for Gaming-Based Bio-Edutainment in Interactive Protein Design. Yallapragada et al. Front Bioeng Biotechnol, 2021 14 May
(opens in a new window)Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors. Eur J Cancer, 2021 2 June
(opens in a new window)Feature Fusion of Raman Chemical Imaging and Digital Histopathology using Machine Learning for Prostate Cancer Detection. Doherty et al. Analyst, 2021 28 Jun
(opens in a new window)OncotypeDX© Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis. Davey et al. Eur J Cancer, 2021 17 July
(opens in a new window)KBoost: a new method to infer gene regulatory networks from gene expression data. Iglesias-Martinez et al. Sci Rep, 2021 29 July
(opens in a new window)The stressosome, a caspase‐8‐activating signalling complex assembled in response to cell stress in an ATG5‐mediated manner. Mnich et al. J Cell Mol Med, 2021 7 Aug
(opens in a new window)PRR11 unveiled as a top candidate biomarker within the RBM3 ‐regulated transcriptome in pancreatic cancer. Hau et al. J Pathol Clin Res, 2021 11 Aug
(opens in a new window)Transcriptional profiling of early differentiation of primary human mesenchymal stem cells into chondrocytes. Schwarzl et al. bioRxiv, 2021 13 August
(opens in a new window)Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer. Silva et al. Clin Epigenetics, 2021 28 Aug
(opens in a new window)Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors. Kennedy et al. Front Oncol, 2021 15 Sep
(opens in a new window)Biopsy bacterial signature can predict patient tissue malignancy. Hogan et al. Sci Rep, 2021, 21 September
(opens in a new window)The Role of BiP and the IRE1α-XBP1 Axis in Rhabdomyosarcoma Pathology. Aghaei et al. Cancers (Basel), 2021 30 Sep
(opens in a new window)Association of circulating short chain fatty acid levels with colorectal adenomas and colorectal cancer. Genua et al. Clin. Nutr. ESPEN, 2021 5 October
(opens in a new window)Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities. Cosgrove et al. Nat Commun, 2022 Jan 26
(opens in a new window)Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity. Wahlin et al. BMC Cancer, 2022 2 Feb
(opens in a new window)Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report. Silva et al. Case Rep Womens Health, 2022 Feb 6
(opens in a new window)A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis. Zhu et al. EMBO Mol Med, 2022 Mar 7
(opens in a new window)Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function. Dyck et al. J Exp Med, 2022 7 Mar
(opens in a new window)Dexamethasone promotes breast cancer stem cells in obese and not lean mice. Annett et al. Pharmacol Res Perspect, 2022 14 March
(opens in a new window)Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism. Monteiro et al. Nat Med, 2022 Apr 11
(opens in a new window)Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer. Almanza et al. Nat Commun, 2022 May 6
(opens in a new window)Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer. Loughman et al. Clin Chem, 2022 Jun 1
(opens in a new window)Temporal and spatial changes in bone mineral content and mechanical properties during breast-cancer bone metastases. Verbruggen et al. Bone Rep, 2022 Jun 12
(opens in a new window)Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells. Bokharaie et al. Biomolecules, 2022 Jul 17
(opens in a new window)Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors. Creedican et al. J Cell Mol Med, 2022 Aug
(opens in a new window)A Systems Biology Approach to Investigate Kinase Signal Transduction Networks That Are Involved in Triple Negative Breast Cancer Resistance to Cisplatin. Mukherjee et al. J Pers Med, 2022 Aug 3
(opens in a new window)Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype. De Santi et al. Mol Ther Nucleic Acids, 2022 Aug 4
(opens in a new window)Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma. Romano et al. Life Sci Alliance, 2022 Aug 29
(opens in a new window)Control of cell state transitions. Rukhlenko et al. Int. J. Mol. Sci, 2022 Sep 14
(opens in a new window)Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response. Antoranz et al. Cancer Res, 2022 Sep 16
(opens in a new window)CRABP2 - A novel biomarker for high-risk endometrial cancer. Egan et al. Gynecol Oncol, 2022 Sep 24
(opens in a new window)Yeast β-Glucan Improves Insulin Sensitivity and Hepatic Lipid Metabolism in Mice Humanized with Obese Type 2 Diabetic Gut Microbiota. Mitchelson et al. Mol Nutr Food Res, 2022 Oct 1
(opens in a new window)Endoplasmic Reticulum Stress-Regulated Chaperones as a Serum Biomarker Panel for Parkinson's Disease. Mnich et al. Mol Neurobiol, 2022 Dec 7
(opens in a new window)1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model. Slater et al. Front Med, 2023 Jan 9
(opens in a new window)Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer. Keelan et al. Cancer Commun (Lond), 2023 20 Jan
(opens in a new window)Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators. Richard et al. Int J Mol Sci, 2023 Feb 9
(opens in a new window)Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma. Hastings et al. Sci Adv, 2023 Mar 3
(opens in a new window)Fluorescence Lifetime Macro Imager for Biomedical Applications. Sen et al. J Vis Exp, 2023 7 Apr
(opens in a new window)Interactome dynamics of RAF1-BRAF kinase monomers and dimers. Iglesias-Martinez et al. Sci Data, 2023 Apr 12
(opens in a new window)Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer. Krzyzanowska et al. Eur Urol Focus, 2023 Apr 25
(opens in a new window)Retinoic acid receptor β modulates mechanosensing and invasion in pancreatic cancer cells via myosin light chain 2. Matellan et al. Oncogenesis, 2023 2 May
(opens in a new window)Unveiling the epigenomic mechanisms of acquired platinum-resistance in high-grade serous ovarian cancer. Silva et al. Int J Cancer, 2023 1 July
(opens in a new window)γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors. Harmon et al. Nat Cancer, 2023 20 July
(opens in a new window)Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells. Liu et al. Int J Mol Sci, 2023 23 Jul
(opens in a new window)Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma. Egan et al. Cancer Immunol Res, 2023 3 Aug
(opens in a new window)Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib. Nolan et al. Cancers, 2023 17 Aug
(opens in a new window)Gene essentiality in cancer is better predicted by mRNA abundance than by gene regulatory network-inferred activity. Tudose et al. NAR Cancer, 2023 28 Nov
(opens in a new window)Systems Biology Approach to Understand the Racial Disparities in Colorectal Cancer. Nwaokorie et al. Cancer Res Commun, 2024 12 Jan
(opens in a new window)Synthetic protein protease sensor platform. Devoy et al. Front Bioeng Biotechnol, 2024 5 Apr
(opens in a new window)RET overexpression leads to increased brain metastatic competency in luminal breast cancer. Jagust et al. J Natl Cancer Inst, 2024 10 Jun
(opens in a new window)BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changes. Arifin et al. iScience, 2024 12 Jun
(opens in a new window)A novel TCF3::PIK3R1 fusion linked to decreased PI3K-AKT signalling activity in paediatric B-acute lymphoblastic leukaemia. Grady et al. Br J Haematol, 2024 14 Jun
(opens in a new window)Genomic and Transcriptomic Analysis of a Patient with Early-Onset Colorectal Cancer and Therapy-Induced Focal Nodular Hyperplasia: A Case Report. O'Reilly et al. J Pers Med, 2024 15 Jun
(opens in a new window)Cell State Transition Models Stratify Breast Cancer Cell Phenotypes and Reveal New Therapeutic Targets. Rukhlenko et al. Cancers (Basel), 2024 27 Jun
(opens in a new window)A temporal (phospho-)proteomic dataset of neurotrophic receptor tyrosine kinase signalling in neuroblastoma. Maher et al. Sci Data, 2024 10 Oct
(opens in a new window)eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations. Valcikova et al. Proc Natl Acad Sci USA, 2024 22 Oct
(opens in a new window)MultiOmicsIntegrator: a nextflow pipeline for integrated omics analyses. Pasat et al. Bioinform Adv, 2024 14 Nov